Accurate and uniform interpretation and reporting of metastatic prostatecancer (PCa) lesions on prostate-specific membrane antigen (PSMA) positronemission tomography/computed tomography (PET/CT) are indispensable.18F-PSMA-1007 is increasingly used because of its favorableimaging characteristics. The gene discussed is FOLH1; the disease is posterior cortical atrophy.